Identification of COVID-19 patients with high Risk of mortality at ICU admiSsion - IRIS-study

  • Funded by Netherlands Organisation for Health Research and Development (ZonMW)
  • Total publications:0 publications

Grant number: 1.043E+13

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2020
    2022
  • Funder

    Netherlands Organisation for Health Research and Development (ZonMW)
  • Principal Investigator

    dr NF. Prof de Keizer
  • Research Location

    N/A
  • Lead Research Institution

    Amsterdam UMC - locatie AMC
  • Research Priority Alignment

    N/A
  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Prognostic factors for disease severity

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Deciding which COVID-19 patients benefit most from treatment in the intensive care unit (ICU) is an important social issue. New COVID-19 patients are admitted every day. Care for non-COVID-19 patients must also continue. The pressure on ICU capacity became very high during the COVID-19 peak in the spring of 2020, and this could repeat itself in the next wave. Research and expected outcomes This study examines patient characteristics that indicate an extremely long ICU stay or a very high risk of death for the patient. Intensivists, other specialists, the patient and relatives can use this knowledge to jointly make an informed decision about the usefulness of an ICU admission. The research uses three data registers (NICE Foundation , CovidPredict and Vektis ). Together, the registers include all ICU patients in the Netherlands, including detailed and long-term outcome information of COVID-19 patients. Analyzes are done using statistical and machine learning techniques.